Recently, shares of China-based pharmaceutical company Su Xuan Tang (SXTC, Financial) experienced a significant surge of 6.30%, reaching $0.670 per share with a trading volume of 196,180 shares. The stock's turnover rate was noted at 5.64%, with a price fluctuation of 10.74%.
Financial results from the latest earnings report indicated that Su Xuan Tang recorded a revenue of $1.93 million. However, the company suffered a net loss of $3.10 million, translating to earnings per share of -$3.57 and a gross profit of $553,971. The price-to-earnings ratio stands at -0.19.
Currently, no institutional ratings such as "buy," "hold," or "sell" have been attributed to the stock. Within the broader pharmaceutical industry, which saw a decline of 0.73%, certain related stocks like Cyclo Therapeutics Inc, Painreform Ltd., and Petros Pharmaceuticals, Inc. noted considerable gains, while Painreform Ltd., Akanda Corp., and Mira Pharmaceuticals, Inc. showed high activity levels with turnover rates of 42.53%, 36.99%, and 14.10%, respectively. Stocks experiencing high volatility included Biofrontera Inc, Painreform Ltd., and Quantum Biopharma Ltd.
Su Xuan Tang Pharmaceutical, based in Jiangsu, China, specializes in the research, development, manufacture, marketing, and sale of Chinese herbal pieces (TCMP), particularly targeted oral Chinese medicine and soakable post-processing TCM, designed for use without decoction.
